4/16/2021  9:59:58 PM Chg. +0.17 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
171.91USD +0.10% 40,178
Turnover: 6.89 mill.
-Bid Size: - -Ask Size: - 35.73 bill.USD 0.56% -

Business description

Founded in 1927 and headquartered in Warsaw, Indiana, USA, Zimmer Biomet is a global leader in musculoskeletal healthcare. The company designs, manufactures and markets orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products.
 

Management board & Supervisory board

CEO
Bryan C. Hanson
Management board
Suketu Upadhyay, Angela Main, Carrie Nichol, Chad Phipps, David J. Kunz, Didier Deltort, Ellie Humphrey, Ivan Tornos, Kenneth R. Tripp, Keri P. Mattox, Rachel Ellingson, Sang Yi, Zeeshan Tariq
Supervisory board
Larry C. Glasscock, Arthur J. Higgins, Betsy J. Bernard, Bryan C. Hanson, Christopher B. Begley, Gail K. Boudreaux, Maria Teresa Hilado, Michael J. Farrell, Michael W. Michelson, Robert A. Hagemann, Sreelakshmi Kolli, Syed Jafry
 

Company data

Name: Zimmer Biomet Holdings Inc.
Address: 345 East Main Street,Warsaw, Indiana 46580, USA
Phone: +1-574-267-6131
Fax: -
E-mail: -
Internet: www.zimmerbiomet.com/
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 83.15%
IPO date: -

Investor relations

Name: Keri Mattox
IR phone: +1-203-399-0856
IR Fax: -
IR e-mail: keri.mattox@zimmerbiomet.com

Company calendar

CW 18 | 4/30/2021 Dividend Payment
CW 19 | 5/4/2021 Interim Report 1st Quarter/3 Months
CW 20 | 5/14/2021 General Shareholder Meeting
 

Main Shareholders

Freefloat
 
83.15%
BlackRock, Inc.
 
9.31%
The Vanguard Group
 
7.54%